Get started
RocketTickers

RARE Announce Positive 64-Week Results for Crysvita® (burosumab)

Long
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)  
RocketTickers  
NASDAQ:RARE   Ultragenyx Pharmaceutical Inc.
Beyond Technical Analysis
1
0
beyondta
2019-02-14 08:30:00
Ultragenyx and Kyowa Kirin Announce Positive 64-Week Results for Crysvita® (burosumab) from Phase 3 Study in Children with X-linked Hypophosphatemia (XLH)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.